Our Services
Medical Information
Helpful Resources
Published on: 2/28/2026
Empagliflozin is well studied and widely recommended for type 2 diabetes, some heart failure, and chronic kidney disease, with proven heart and kidney protection and modest improvements in A1C, weight, and blood pressure.
Rare but serious risks like euglycemic ketoacidosis, dehydration or low blood pressure, and severe genital infections mean you should follow medically approved steps such as staying hydrated, smart monitoring, knowing sick-day pauses, and when to seek urgent care, all outlined below. There are several factors to consider; see details below to understand more.
If you've been prescribed empagliflozin and feel concerned about taking it, you're not alone. It's normal to have questions about any medication—especially one used to treat conditions like type 2 diabetes, heart failure, or chronic kidney disease.
The good news? Empagliflozin is well studied, widely used, and backed by strong clinical evidence. But like any medication, it has benefits, risks, and important safety considerations. Let's walk through what the science says and what you should do next.
Empagliflozin (brand name commonly known as Jardiance) is a prescription medication used to:
It belongs to a class of drugs called SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors).
Empagliflozin works through your kidneys. It:
This mechanism is different from insulin or many older diabetes medications.
Large clinical trials have shown that empagliflozin provides meaningful benefits beyond blood sugar control.
According to major clinical trials such as EMPA-REG OUTCOME and EMPEROR trials, empagliflozin can:
These benefits are why many medical guidelines now recommend empagliflozin early in treatment—especially for patients with heart or kidney risks.
Most people tolerate empagliflozin well. However, side effects can happen.
These occur because the medication increases glucose in urine, which can promote infections and fluid loss.
Staying hydrated and practicing good hygiene can reduce risk.
It's important not to ignore the more serious risks—but also not to panic. They are uncommon, especially when monitored appropriately.
Empagliflozin can, in rare cases, cause euglycemic diabetic ketoacidosis—a serious condition where the body produces too many ketones even if blood sugar is not extremely high.
Seek urgent medical care if you have:
This is uncommon but potentially life-threatening.
Higher urination can lead to:
This risk is higher if you:
Empagliflozin may cause a small, temporary drop in kidney function when starting the medication. In most cases, this stabilizes and provides long-term protection.
Your doctor will monitor kidney labs.
A rare but serious infection of the genital area has been reported with SGLT2 inhibitors.
It is very uncommon. Seek urgent care for:
Again, this is rare—but serious.
You should speak to a doctor immediately if you experience:
These may signal something serious or life-threatening.
If symptoms feel urgent or severe, do not wait—seek emergency care.
Many concerns about empagliflozin stem from reading long side-effect lists. It's important to understand:
Your prescribing provider considered your health profile before recommending this medication.
Empagliflozin may not be appropriate if you:
Always disclose:
If you're worried about empagliflozin, take calm, practical steps:
Ask yourself:
Understanding the reason helps reduce anxiety.
If you're taking empagliflozin:
Bring these to your doctor:
Open communication reduces uncertainty.
Many doctors recommend temporarily stopping empagliflozin during:
This helps reduce DKA risk.
Never stop long-term medication without medical advice—but ask about "sick day rules."
If you've been prescribed empagliflozin but aren't certain whether your symptoms align with Diabetes Mellitus, a free AI-powered symptom checker can help you understand what you're experiencing and prepare better questions for your next doctor's visit.
Empagliflozin is:
But it is not risk-free.
The key is informed use, monitoring, and communication with your healthcare provider.
Seek urgent care or contact a healthcare professional right away if you experience:
These may indicate life-threatening complications.
Being concerned about empagliflozin doesn't mean you should stop it. It means you care about your health.
The science shows real benefits—especially for people with type 2 diabetes, heart failure, or kidney disease. The risks are real but manageable with proper monitoring.
The best next step is simple:
Good medicine is a partnership. If you're unsure, uncomfortable, or experiencing symptoms, do not ignore them. A conversation with your healthcare provider is always the safest move.
(References)
* Butler, J., Fonarow, G. C., Zannad, F., Filippatos, G., Pitt, B., Anker, S. D., ... & American Heart Association Council on Clinical Cardiology; Council on the Kidney in Cardiovascular Disease; and Council on Hypertension. (2022). Empagliflozin in heart failure, kidney disease and diabetes: A scientific statement from the American Heart Association. *Circulation*, *146*(9), e157-e179.
* Kohli, R., Majumder, S., Tuncel, M., Sunkara, B., Nimmagadda, N., Tella, S., ... & Madan, R. (2016). Safety and tolerability of empagliflozin in patients with type 2 diabetes: a comprehensive review of clinical trials. *Current Medical Research and Opinion*, *32*(6), 1109-1117.
* Syed, Y. Y. (2015). Empagliflozin: a review of its use in the management of type 2 diabetes mellitus. *Drugs*, *75*(17), 2059-2073.
* The EMPA-KIDNEY Collaborative Group. (2022). Empagliflozin for treatment of chronic kidney disease in patients with and without diabetes. *New England Journal of Medicine*, *388*(2), 117-127.
* Zheng, X., & Kloner, R. A. (2023). A Clinical Perspective of SGLT2 Inhibitors for Renal and Cardiovascular Disease. *Clinical Cardiology*, *46*(6), 724-733.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.